Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

CAP TODAY

Sample storage, shipping system

February 2020—DriBank Labs announced the availability of its DriBank system for preserving, storing, and shipping laboratory samples. The system preserves small (≤ 3 g or 50 µL) laboratory biological samples at room temperature (20˚C) for up to six months using desiccants contained inside a replaceable and rechargeable cartridge, eliminating the need for chemical fixatives or refrigerants. It accepts samples in a variety of media including microscope slides, microcentrifuge tubes, cell culture dishes, swabs, and others.

NeuMoDx, Sentinel partnership

February 2020—NeuMoDx Molecular and Sentinel Diagnostics announced a partnership to develop diagnostic assays for the NeuMoDx 96 and 288 molecular systems. Sentinel’s real-time PCR assays will be adapted to the NeuMoDx 96 and 288 molecular systems and will incorporate Sentinel’s STAT-NAT technology, which provides the ability to stabilize the activity of a PCR mix, allowing room-temperature storage and transport. The test menu pipeline for the systems will include assays to detect and monitor post-transplant infections, parasitic and hospital-acquired infections, and respiratory infections, and for pharmacogenetics applications.

ArcherDX, Illumina comarketing partnership

February 2020—ArcherDX announced a nonexclusive, multiyear partnership with Illumina intended to broaden access of next-generation-sequencing­–based oncology testing, including companion diagnostics for therapeutic selection, personalized monitoring, and recurrence surveillance IVD tests, upon FDA approval.

 

Horizon Discovery launches new website

February 2020—Horizon Discovery Group went live with a new website and ecommerce system, horizondiscovery.com. Features of the website are improved navigation, including sophisticated gene-based search capabilities and advanced filtering, an intuitive, streamlined purchasing and quotation system, and comprehensive technical support and educational content.

β-hydroxybutyrate prefilled reagent kits

February 2020—Vidan Diagnostics announced the availability of its β-Hydroxybutyrate 21FS prefilled reagent kits, for the quantitative in vitro determination of beta-hydroxybutyrate in serum or plasma, for use with Abbott Architect and Beckman Coulter AU systems.

FDA clears Curetis Unyvero LRT for BAL specimens

February 2020—Curetis announced it has received FDA 510(k) clearance to market its Unyvero LRT Lower Respiratory Tract application cartridge for use with bronchoalveolar lavage samples to diagnose lower respiratory tract infections such as pneumonia.

Verichem calibration verification kits

February 2020—Verichem Laboratories announced the availability of its HDL Cholesterol Verifier kit intended for the calibration verification of HDL and LDL cholesterol assays. The kit contains high-density and low-density lipoprotein cholesterol from human serum in a ready-to-use, liquid stable format that is free of surfactants, glycols, and azide.

Karius test detects bloodstream infection in pediatric patients

February 2020—Karius announced that JAMA Oncology published a clinical study showing that the Karius test detected bloodstream infections before the onset of clinical symptoms in high-risk pediatric patients with relapsed or refractory leukemia (Goggin KP, et al. Epub ahead of print Dec. 19, 2019. doi:10.1001/jamaoncol.2019.4120). The study was performed by researchers at St. Jude Children’s Research Hospital.

Quest buys clinical lab services of BCL

February 2020—Quest Diagnostics has acquired certain assets of the clinical laboratory services business of Boston Clinical Laboratories, based in Waltham, Mass.

FoundationOne CDx gets expanded approval

February 2020—Foundation Medicine has received FDA approval for its FoundationOne CDx to be used as a companion diagnostic for Piqray (alpelisib) in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor–positive, human epidermal growth factor receptor 2–negative, PIK3CA-mutated advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

MARKETPLACE

TRENDING